About Ascent Innovative Medicines
Ascent Innovative Medicines was a Healthcare company based in Mumbai (India). Educational platform simplifying plasma-derived therapies for healthcare users. It operates on a B2B model. The company has 8 employees. Its Indian entity Ascent Innovative Medicines Private Limited reported revenue of ₹9.6 Lakh. The company is recorded as dissolved. Ascent Innovative Medicines offers products and services including Albumin Academy. Its focus areas include Biotechnology, Plasma Therapies, Educational Services and Education Tech. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Takeda provides the Albumin Academy, a learning module that explains complex anatomy and physiology of plasma-derived therapies, which are vital for treating rare diseases. It uses visual presentations to help business executives and trainers understand these therapies, enabling them to confidently discuss benefits and address customer queries. The academy focuses on educational content to support healthcare-related knowledge sharing.
- Headquarters Mumbai, India
- Employees 8
- SectorsHealthcare
- Website ascentinnovative.com
- Legal Name Ascent Innovative Medicines Private Limited
- Date of Incorporation 24 Feb, 2016
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹9.6 Lakh
FY 2025 · -83% YoY
- Net Loss-₹25.5 Lakh
FY 2025 · -267% margin
- EBITDA-₹25.5 Lakh
FY 2025 · -267% margin
- Employee Count8
Associated legal entities of Ascent Innovative Medicines
Ascent Innovative Medicines operates through Ascent Innovative Medicines Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ascent Innovative Medicines Private Limited CIN U74900MH2016PTC273442 | Active | 24 Feb 2016 | Mumbai, Maharashtra | ₹0.1 Cr | 8 | 2 | View details |
Products & Services of Ascent Innovative Medicines
Ascent Innovative Medicines offers a comprehensive portfolio of products and services, including Albumin Academy.
Learning module simplifying plasma-derived therapies for user education.
Board of directors of Ascent Innovative Medicines Private Limited (Ascent Innovative Medicines)
Ascent Innovative Medicines Private Limited is the primary company behind Ascent Innovative Medicines. The board of Ascent Innovative Medicines Private Limited currently have 2 directors; the longest-serving is Subodh Gupta, appointed in 2016. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subodh Gupta DIN 00141025 | Managing Director | 24 Feb 2016 | 10 yrs 8 mo | Ascent Innovative Medicines Private Limited |
| Suresh Mahabirprasad Deora DIN 00914688 | Director | 24 Feb 2016 | 10 yrs 8 mo | Ascent Innovative Medicines Private Limited |
Financials of Ascent Innovative Medicines
Figures of Ascent Innovative Medicines Private Limited, the primary company behind Ascent Innovative Medicines, for FY 2025. Revenue was ₹9.6 Lakh (-83% year on year). Net loss was -₹25.5 Lakh (-267% margin). EBITDA was -₹25.5 Lakh (-267% margin). Revenue has grown at a compounded annual rate of -58% over three years and -47% over five years.
- ₹9.6 LakhRevenue · FY 2025 · -83% YoY
- -₹25.5 LakhNet loss · -267% margin
- -₹25.5 LakhEBITDA · -267% margin
- ₹5.00 CrPaid-up capital
- 8Employees (provident fund records)
- -58%Revenue CAGR, 3 years
- -47%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ascent Innovative Medicines Private Limited are on its company page.
Detailed financial statements for Ascent Innovative Medicines
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Ascent Innovative Medicines
Ascent Innovative Medicines has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Ascent Innovative Medicines
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ascent Innovative Medicines
Ascent Innovative Medicines is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ascent Innovative Medicines has 8 employees.
The primary company behind Ascent Innovative Medicines, Ascent Innovative Medicines Private Limited, reported revenue of ₹9.6 Lakh for FY 2025, down 83% year on year.
Takeda provides the Albumin Academy, a learning module that explains complex anatomy and physiology of plasma-derived therapies, which are vital for treating rare diseases. It uses visual presentations to help business executives and trainers understand these therapies, enabling them to confidently discuss benefits and address customer queries. The academy focuses on educational content to support healthcare-related knowledge sharing.
Ascent Innovative Medicines's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Ascent Innovative Medicines offers Albumin Academy.
Ascent Innovative Medicines operates through Ascent Innovative Medicines Private Limited.
The legal entities of Ascent Innovative Medicines currently have 2 directors, including Subodh Gupta, Suresh Mahabirprasad Deora.